WO2006060202A3 - Imidazole derivatives for the treatment of psychiatric disorders - Google Patents
Imidazole derivatives for the treatment of psychiatric disorders Download PDFInfo
- Publication number
- WO2006060202A3 WO2006060202A3 PCT/US2005/042007 US2005042007W WO2006060202A3 WO 2006060202 A3 WO2006060202 A3 WO 2006060202A3 US 2005042007 W US2005042007 W US 2005042007W WO 2006060202 A3 WO2006060202 A3 WO 2006060202A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- psychiatric disorders
- imidazole derivatives
- imidazole
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63202804P | 2004-11-30 | 2004-11-30 | |
| US60/632,028 | 2004-11-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2006060202A2 WO2006060202A2 (en) | 2006-06-08 |
| WO2006060202A3 true WO2006060202A3 (en) | 2006-12-14 |
Family
ID=36565537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2005/042007 Ceased WO2006060202A2 (en) | 2004-11-30 | 2005-11-18 | Imidazole derivatives for the treatment of psychiatric disorders |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2006060202A2 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040235854A1 (en) * | 2001-09-21 | 2004-11-25 | Kruse Cornelis G. | 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity |
| US20040248956A1 (en) * | 2002-01-29 | 2004-12-09 | Hagmann William K | Substituted imidazoles as cannabinoid receptor modulators |
-
2005
- 2005-11-18 WO PCT/US2005/042007 patent/WO2006060202A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040235854A1 (en) * | 2001-09-21 | 2004-11-25 | Kruse Cornelis G. | 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity |
| US20040248956A1 (en) * | 2002-01-29 | 2004-12-09 | Hagmann William K | Substituted imidazoles as cannabinoid receptor modulators |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006060202A2 (en) | 2006-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2379A (en) | Imidazole compounds for the treatment of neurodegenerative disorders. | |
| WO2006071960A3 (en) | Compositions and methods of treating cell proliferation disorders | |
| IL189990A0 (en) | 5-(phenylisoxazolylethoxy) -triazol-3-yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders | |
| HRP20130797T1 (en) | Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase | |
| IL180736A0 (en) | Hydantoin derivatives for the treatment of inflammatory disorders | |
| IL208607A0 (en) | Improved nanobodiestm for the treatment of aggregation-mediated disorders | |
| WO2005079756A3 (en) | Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions | |
| WO2006017384A3 (en) | Indazoles useful in treating cardiovascular diseases | |
| WO2005086656A3 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
| WO2006018188A3 (en) | Substituted hydantoins | |
| IL186748A0 (en) | 4 - phenyl - 5 - oxo 1, 4, 5, 6, 7, 8 - hexahydroquinoline derivatives for the treatment of infertility | |
| SI1900362T1 (en) | Alfa-aminoamide derivatives useful in the treatment of addictive disorders | |
| ZA200805159B (en) | Imidazole derivatives for the treatment of gastrointestinal disorders | |
| WO2007047447A3 (en) | Diuretic-like compound analogs useful for regulation of central nervous system disorders | |
| IL189524A0 (en) | Imidazole compounds for the treatment of neurological disorders | |
| EP1814535A4 (en) | Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders | |
| WO2008050133A3 (en) | Inhibition of beta-amyloid aggregation | |
| WO2005112923A3 (en) | 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes | |
| WO2007030438A3 (en) | Aminopurine derivatives for treating neurodegenerative diseases | |
| WO2006060202A3 (en) | Imidazole derivatives for the treatment of psychiatric disorders | |
| MX2007009108A (en) | Imidazole derivatives. | |
| WO2006060201A3 (en) | Pyrazole derivatives for the treatment of psychiatric disorders | |
| WO2006060203A3 (en) | Imidazole derivatives for the treatment of dementia and related disorders | |
| WO2006060199A3 (en) | Imidazole derivatives for the treatment of sexual dysfunction | |
| WO2006060192A3 (en) | Pyrazole derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 05849389 Country of ref document: EP Kind code of ref document: A2 |